title: Inhibition of Henipavirus infection by RNA interference.
abstract: Nipah virus (NiV) and Hendra virus (HeV) are recently emerged zoonotic paramyxoviruses exclusively grouped within a new genus, Henipavirus. These viruses cause fatal disease in a wide range of species, including humans. Both NiV and HeV have continued to re-emerge sporadically in Bangladesh and Australia, respectively. There are currently no therapeutics or vaccines available to treat Henipavirus infection and both are classified as BSL4 pathogens. RNA interference (RNAi) is a process by which double-stranded RNA directs sequence-specific degradation of messenger RNA in animal and plant cells. Small interfering RNAs (siRNAs) mediate RNAi by inhibiting gene expression of homologous mRNA and our preliminary studies suggest RNAi may be a useful approach to developing novel therapies for these highly lethal pathogens. Eight NiV siRNA molecules (four L and four N gene specific), two HeV N gene specific, and two non-specific control siRNA molecules were designed and tested for their ability to inhibit a henipavirus minigenome replication system (which does not require the use of live virus) in addition to live virus infections in vitro. In the minigenome assay three out of the four siRNAs that targeted the L gene of NiV effectively inhibited replication. In contrast, only NiV N gene siRNAs were effective in reducing live NiV replication, suggesting inhibition of early, abundantly expressed gene transcripts may be more effective than later, less abundant transcripts. Additionally, some of the siRNAs effective against NiV infection were only partially effective inhibitors of HeV infection. An inverse correlation between the number of nucleotide mismatches and the efficacy of siRNA inhibition was observed. The demonstration that RNAi effectively inhibits henipavirus replication in vitro, is a novel approach and may provide an effective therapy for these highly lethal, zoonotic pathogens.
authors.affiliation: Australian Animal Health Laboratory, CSIRO Livestock Industries, Geelong, Australia. Bruce.Mungall@csiro.au
authors.forename: Bruce A
authors.initials: BA
authors.lastname: Mungall
authors.forename: Nick C T
authors.initials: NC
authors.lastname: Schopman
authors.forename: Luke S
authors.initials: LS
authors.lastname: Lambeth
authors.forename: Tim J
authors.initials: TJ
authors.lastname: Doran
mesh_terms: D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D002522:Chlorocebus aethiops; D006224:Cricetinae; D016679:Genome, Viral; D045403:Henipavirus / Q000235:genetics* / Q000502:physiology; D045464:Henipavirus Infections / Q000235:genetics / Q000628:therapy* / Q000662:veterinary / Q000821:virology*; D006734:Horse Diseases / Q000821:virology*; D006736:Horses; D006801:Humans; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000235:genetics; D016415:Sequence Alignment; D014709:Vero Cells; D014779:Virus Replication
chemical_list: D034741:RNA, Small Interfering